Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Survey on SARS-CoV-2 antibody titers and health after additional vaccination
jRCT1061210049Active, not recruiting
- Sponsor
- Kawasaki Medical School
- Start
- Nov 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial of SARS-CoV-2 vaccine in coronavirus disease 2019 (COVID-19), sponsored by Kawasaki Medical School. Started Nov 2021; status: active, not recruiting.
02
Drugs
SARS-CoV-2 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT1061210049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061210049.